GB9906993D0 - Psoriasis - Google Patents

Psoriasis

Info

Publication number
GB9906993D0
GB9906993D0 GBGB9906993.2A GB9906993A GB9906993D0 GB 9906993 D0 GB9906993 D0 GB 9906993D0 GB 9906993 A GB9906993 A GB 9906993A GB 9906993 D0 GB9906993 D0 GB 9906993D0
Authority
GB
United Kingdom
Prior art keywords
psoriasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9906993.2A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Leicester
Original Assignee
University of Leicester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Leicester filed Critical University of Leicester
Priority to GBGB9906993.2A priority Critical patent/GB9906993D0/en
Publication of GB9906993D0 publication Critical patent/GB9906993D0/en
Priority to EP00912820A priority patent/EP1144678A2/fr
Priority to PCT/GB2000/001152 priority patent/WO2000058506A2/fr
Priority to CA002329261A priority patent/CA2329261A1/fr
Priority to AU34462/00A priority patent/AU3446200A/en
Priority to JP2000608784A priority patent/JP2002539844A/ja
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G01N2800/205—Scaling palpular diseases, e.g. psoriasis, pytiriasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB9906993.2A 1999-03-26 1999-03-26 Psoriasis Ceased GB9906993D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9906993.2A GB9906993D0 (en) 1999-03-26 1999-03-26 Psoriasis
EP00912820A EP1144678A2 (fr) 1999-03-26 2000-03-27 Depistage d'une predisposition au psoriasis
PCT/GB2000/001152 WO2000058506A2 (fr) 1999-03-26 2000-03-27 Depistage d'une predisposition au psoriasis
CA002329261A CA2329261A1 (fr) 1999-03-26 2000-03-27 Depistage d'une predisposition au psoriasis
AU34462/00A AU3446200A (en) 1999-03-26 2000-03-27 Susceptibility to psoriasis
JP2000608784A JP2002539844A (ja) 1999-03-26 2000-03-27 乾癬に対する感受性

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9906993.2A GB9906993D0 (en) 1999-03-26 1999-03-26 Psoriasis

Publications (1)

Publication Number Publication Date
GB9906993D0 true GB9906993D0 (en) 1999-05-19

Family

ID=10850413

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9906993.2A Ceased GB9906993D0 (en) 1999-03-26 1999-03-26 Psoriasis

Country Status (6)

Country Link
EP (1) EP1144678A2 (fr)
JP (1) JP2002539844A (fr)
AU (1) AU3446200A (fr)
CA (1) CA2329261A1 (fr)
GB (1) GB9906993D0 (fr)
WO (1) WO2000058506A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1731201A (en) * 1999-12-06 2001-06-18 Hidetoshi Inoko Method of examining vulgar psoriasis
GB0004312D0 (en) * 2000-02-23 2000-04-12 Oxagen Limited Test and model for inflammatory disease
AU2085502A (en) * 2000-11-30 2002-06-11 Molecular Skincare Ltd Diagnosis and treatment of disease
FR2853910B1 (fr) * 2003-04-16 2007-08-24 Galderma Res & Dev Genes du psoriasis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2761363B1 (fr) * 1997-03-28 1999-11-26 Oreal Polypeptide purifie de l'epiderme et son utilisation
FR2761362B1 (fr) * 1997-03-28 1999-05-21 Oreal Polypeptide purifie de l'epiderme et son utilisation

Also Published As

Publication number Publication date
CA2329261A1 (fr) 2000-10-05
JP2002539844A (ja) 2002-11-26
EP1144678A2 (fr) 2001-10-17
AU3446200A (en) 2000-10-16
WO2000058506A2 (fr) 2000-10-05
WO2000058506A3 (fr) 2001-08-16

Similar Documents

Publication Publication Date Title
DE50002490D1 (en) Polyester-polyetherblockcopolymere
DE60018288D1 (en) Polyphenylensulfidlegierungszusammensetzung
DE50002614D1 (en) Sigma-delta-modulator
IL148218A0 (en) New phenylpiperazines
DE50000137D1 (en) Spirofluorenopyrane
DE10081629D2 (en) Seilzugbefestigung
HK1048307A1 (zh) 取代的雜環基-2h-苯並吡喃類化合物
GB9911452D0 (en) Benzofuranylsulfonates
DE60026282D1 (en) Photovervielfacherröhre
AU141428S (en) Turnpiece
GB9906993D0 (en) Psoriasis
GB9911456D0 (en) Oligohydroxyl substituted 3-urea-benzofurane-and-pyridofurane-derivatives
DE60007846D1 (en) Sterndreieckschalter
PL352101A1 (en) Substituted phenylcyclohexanocarboxyamides
IL150057A0 (en) Nitro-sulfobenzamides
DE50005334D1 (en) Tricyclische benzoylcyclohexandion-derivate
AU140373S (en) Bumbag
GB9924796D0 (en) Rotorhead
GB9914278D0 (en) Instantent
EG22401A (en) Set 3c1-strong
DE50005597D1 (en) Laryngoskop
CA87158S (en) Pendulette
HU9902485D0 (en) Exclusive curddessert
AU143981S (en) Neckerchief
GB9926387D0 (en) Infotrans

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)